The BRCA1 and BRCA2 mutations increase the susceptibility to breast or ovarian cancer, and it has been estimated that the probability of developing these forms of cancer is between 30 and 80% in individuals carrying hetero- or homozygous mutations in these genes (Brody and Biesecker, 1998). This evidence concerns the gene BRCA2 and ovarian cancer.